Cargando…
Severe Hypertriglyceridemia Induced by Docetaxel: A Novel Case Report
Docetaxel (DOC) is one of the most effective agents for breast cancer treatment. Here, we report docetaxel-induced severe hypertriglyceridemia in a patient previously diagnosed with hyperlipidemia and corresponding therapeutic intervention. A postmenopausal woman, with previously controlled hyperlip...
Autores principales: | Saito, Yoshitaka, Takekuma, Yoh, Takeshita, Takashi, Sugawara, Mitsuru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460953/ https://www.ncbi.nlm.nih.gov/pubmed/34720928 http://dx.doi.org/10.1159/000518684 |
Ejemplares similares
-
Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report
por: Saito, Yoshitaka, et al.
Publicado: (2021) -
Impact of systemic dexamethasone dosage on docetaxel-induced oral mucositis in patients with breast cancer
por: Saito, Yoshitaka, et al.
Publicado: (2023) -
Pregabalin Attenuates Carboplatin-Induced Akathisia-Like Neuropathy: A Novel Case Report
por: Saito, Yoshitaka, et al.
Publicado: (2021) -
High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment
por: Saito, Yoshitaka, et al.
Publicado: (2023) -
Temporary Severe Neutropenia during Administration of Atezolizumab: A Novel Case Report
por: Kanno, Ryota, et al.
Publicado: (2023)